REG - hVIVO plc - Result of AGM <Origin Href="QuoteRef">HVO.L</Origin>

hVIVOAnnouncement

15/07/2015 19:19

RNS Number : 2274O
hVIVO plc
26 May 2015
For immediate release 12.00pm: 26 May 2015
HVIVO PLC
("hVIVO" or the "Company")
Result of Annual General Meeting
hVIVO plc (AIM: RVG), the pioneer of human challenge models of disease, is pleased to announce that all resolutions proposed at its Annual General Meeting, held at 10am on 21 May 2015, were duly passed.
For further information please contact:
hVIVO plc+44 207 756 1300
Kym Denny (Chief Executive Officer)
Graham Yeatman (Chief Financial & Business Officer) 
Media Enquiries+44 203 021 3933 / +44 7854 979 420
Colin Paterson (Director of Marketing, Communication and Public Relations)
 
Numis Securities Limited  +44 207 260 1000 
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
Notes to Editors:
hVIVO plc ("hVIVO") is a life sciences company pioneering a technology platform of human disease models to accelerate drug development and discovery in respiratory and infectious diseases. Based in the UK, hVIVO has conducted over 40 clinical studies, involving more than 1950 volunteers for a range of leading industry, governmental and academic clients.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RAGPKADPKBKDOPB